Krka, our multinational pharmaceutical business group, is composed of the controlling company in Slovenia, subsidiaries, and registered offices in more than 40 countries. We employ over 12,000 personnel globally. Performance and other indicators place us among the top global generic pharmaceutical manufacturers. Innovative products, investments and expansion to new markets warrant market share increases and good business performance.
We understand that the social development is mirrored in the need for medicines and health care for all people, so our core products are prescription pharmaceuticals for most common diseases of our time. We are present in Slovenia and in generic pharmaceutical markets of western, eastern, central and south-eastern Europe, and have extended our presence also to overseas markets, especially the Middle and Far East, Africa, Central America, and China. Not only in Slovenia, our products are also manufactured in Croatia, Poland, the Russian Federation, and Germany.
From start to finish, everything we do revolves around patients with the aim to help them preserve and improve their health. Krka’s medicines marketed under our own brand names are used to treat approximately 50 million patients in more than 70 countries every day.
Our state-of-the art manufacturing facilities in Slovenia and elsewhere produce 17 billion pieces of solid dosage forms a year. Digitalisation and highly automated and computerised manufacturing design provide for constantly high quality and at the same time improve cost effectiveness and responsiveness of our business process. The vertically integrated business model allows for a high degree of innovation and guarantees high quality of the entire manufacturing process, from development of an API, pharmaceutical dosage form and analytical methods, to production, packaging, distribution, and marketing.
Sustainable development is an important strategic aspect considered throughout our business.